Clinical factors associated with venous thromboembolism in multiple myeloma patients treated with daratumumab

Abstract Background Venous thromboembolism (VTE) is a common cause of morbidity and mortality in patients with multiple myeloma (MM). There has been little evidence investigating the factors associated with VTE during therapy with daratumumab-containing regimens. Objectives Our study examined the as...

Descripció completa

Dades bibliogràfiques

Autors principals:	Naveen G. Subramanian, Fleur M. Aung, Zachary E. Hunzeker, Krina K. Patel, Hans C. Lee, Shida Jin, Elliana Young, Roland L. Bassett, Cristhiam M. Rojas Hernandez
Format:	Artigo
Idioma:	Inglês
Publicat:	Springer Nature 2026-02-01
Col·lecció:	Discover Medicine
Matèries:	Thromboprophylaxis Multiple myeloma Natural language processing Risk Venous thromboembolism
Accés en línia:	https://doi.org/10.1007/s44337-026-00568-x
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!